Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 02, 2015 7:15 AM ET

Pharmaceuticals

Company Overview of Bharat Serums and Vaccines Limited

Company Overview

Bharat Serums and Vaccines Limited, a biopharmaceutical company, researches, develops, manufactures, and markets injectable biological, pharmaceutical, and biotechnology products. Its products portfolio includes plasma derivatives, monoclonals, fertility hormones, antifungals, anesthetics, cardiovascular drugs, and equine immunoglobulins/antitoxins. The company also engages in the research and development of drug delivery systems, biotechnology/recombinant therapeutics, and biological/equine products; development of recombinant molecules, such as cell lines and lab scale processes for biosimilar products; and research, development, and manufacture of therapeutic proteins. In addition, it off...

DIL Complex Office

1st Floor, Building No. 1

Business Development Centre, Near Tatwagyan Vidyap

Ghodbhunder Road, Thane(W)

Thane,  400 610

India

Founded in 1971

Phone:

91 22 6138 3456

Fax:

91 22 6138 3400

Key Executives for Bharat Serums and Vaccines Limited

Chairman of the Board and Co-Managing Director
Vice Chairman and Co-Managing Director
Finance Director
Compensation as of Fiscal Year 2015.

Bharat Serums and Vaccines Limited Key Developments

Carlyle Reportedly In Talks With Bharat Serums

The Carlyle Group LP (NasdaqGS:CG) is in talks with Bharat Serums and Vaccines Limited. Carlyle in negotiating with Bharat Serums to buy a significant minority stake in the latter from existing investors for INR 5 billion-INR 6 billion. The company is in discussion to buy the 15% stake held by Kotak Mahindra Bank Limited’s (BSE:500247) private equity arm as well as another 8%-10% held by OrbiMed Advisors, L.L.C. According to sources close to the matter, Carlyle is likely to buy about 25%-30% stake in Bharat Serums. The report mentioned that it is not clear whether the promoters will dilute their stake in this round of fundraising. The news report mentioned that a Carlyle spokesperson said, “As company policy, Carlyle does not comment on market speculation,” while mails to Gautam Daftary, Vice-Chairman and Managing Director of Bharat Serums, and Deshmukh of Kotak Investment Advisors Limited went unanswered.

Bharat Serums and Vaccines Limited Presents at BioPharma India 2013, Nov-25-2013 through Nov-26-2013

Bharat Serums and Vaccines Limited Presents at BioPharma India 2013, Nov-25-2013 through Nov-26-2013. Venue: Hyatt Regency, Mumbai, Maharashtra, India. Presentation Date & Speakers: Nov-26-2013, Sagnik Sengupta, General Manager, Distribution.

Similar Private Companies By Industry

Company Name Region
Blue Cross Laboratories Ltd. Asia
Zydus Recon Healthcare Ltd. Asia
Orissa Drugs and Chemicals Ltd. Asia
Innovance Asia
Avigna Chemitech Private Limited Asia

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
March 26, 2015
Zydus BSV Pharma Pvt. Ltd.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bharat Serums and Vaccines Limited, please visit www.bharatserums.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.